Blog Particle 1
Blog Particle 2

News & updates from Zinc HQ

Trapping brain cancer: Why Zinc is backing Migration BioTherapeutics
6 MINS READ
Trapping brain cancer: Why Zinc is backing Migration BioTherapeutics
April 28, 2026 By Kate Hyslop
6 MINS READ

Tackling heart disease at its roots: Why Zinc invested in SignaCor

March 30, 2026 By Natalie Pankova, PhD
7 MINS READ

Introducing IonSight: The measurement engine behind the future of drug discovery

March 9, 2026 By Kate Hyslop
7 MINS READ

Zinc backs BioHarv: the future of battery-free, heart-powered medical devices

February 3, 2026 By Emilie Syed
8 MINS READ

Our Mission for 2026: Unlocking the Potential of Science-for-Impact

January 20, 2026 By Paul Kirby & Ella Goldner
7 MINS READ

Meet Rhizo PTX: Rethinking Green Ammonia Production

December 9, 2025 By Kate Hyslop
5 MINS READ

Zinc Backs Anemo Labs to Build the Future of Medical Olfaction

November 24, 2025 By Kate Hyslop
8 MINS READ

Introducing Zinc’s 2025 Science-for-Impact Report

October 14, 2025 By Kate Hyslop
6 MINS READ

Increasing buy-in for behavioural research: are investors the key?

April 10, 2025 By Rosie Webster
6 MINS READ

Tools, resources, and training for behavioural research

April 1, 2025 By Maria Fomina, Rosie Webster
8 MINS READ

Meet Cambridge Medixine: Unlocking the next generation of mRNA therapeutics

March 31, 2025 By Kate Hyslop
5 MINS READ

Report: The state of behavioural research in UK ventures and what comes next

March 26, 2025 By Maria Fomina, Rosie Webster
8 MINS READ

Founder spotlight: Meet the women building Science-for-Impact ventures at Zinc

March 18, 2025 By Diellza Ramadani